Skip to main
CBLL

Ceribell Inc (CBLL) Stock Forecast & Price Target

Ceribell Inc (CBLL) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CeriBell Inc is poised for significant growth, projecting revenues of $87 million to $89 million in 2025, reflecting an anticipated annual increase of 33% to 36%, largely due to strong seasonal performance and strategic investments in its salesforce. The company's innovative Ceribell System, which combines portable hardware with AI algorithms for rapid neurological diagnostics, positions it to capitalize on expanding market opportunities in various healthcare settings, including VA hospitals and pediatric populations. Additionally, CeriBell benefits from a high gross margin of approximately 80%, a dual revenue stream business model, and a robust financial strategy aimed at achieving cash-flow breakeven, all of which contribute to a positive long-term outlook.

Bears say

CeriBell Inc. is currently experiencing significant financial challenges, reporting a net loss of $40 million in the most recent year and lacking free cash flow positivity, which casts doubt on its operational sustainability. The company faces additional margin pressures due to tariffs and legal expenses, compounded by uncertainties that could arise from geopolitical risks, particularly concerning its reliance on Chinese imports. Furthermore, a low market capitalization combined with a history of operating losses and a limited penetration rate in existing accounts highlights the company's aggressive risk profile and vulnerability to potential downturns in customer demand and competitive dynamics.

Ceribell Inc (CBLL) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 83% of analysts recommend a Strong Buy, 17% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ceribell Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ceribell Inc (CBLL) Forecast

Analysts have given Ceribell Inc (CBLL) a Strong Buy based on their latest research and market trends.

According to 6 analysts, Ceribell Inc (CBLL) has a Strong Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ceribell Inc (CBLL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.